Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.

BioSpace
Claim This Podcastby BioSpace
Podcast Authority
Beta
Podcast Overview
Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.
Language
🇺🇲
Publishing Since
11/8/2023
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
3 verified contact emails on file for BioSpace
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

June 18, 2026
From fragile skin to living medicine: Lessons from RDEB
Host Jennifer C. Smith-Parker interviews Mark Lowdell and Vishwas Seshadri about how recessive dystrophic epidermolysis bullosa informs cell and gene therapy advancements.

June 17, 2026
Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more
This episode covers Moderna's mRNA flu vaccine FDA review, record-breaking biotech IPOs, and biopharma layoffs, offering insights into industry trends.

June 10, 2026
Portugal, Spain and the new biotech frontier
Jennifer C. Smith-Parker interviews Hannah Franklin and Pablo Gabriel Cironi Lopez about Southern Europe's burgeoning biotech landscape and its global competitiveness.
240 total episodes available with 50 transcripts
Recent guests on BioSpace
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Mark Lowdell
Guest
Vishwas Seshadri
Guest
Hannah Franklin
Guest
Pablo Gabriel Cironi Lopez
Guest
Daniel Gil
Guest
Francisco Ramírez-Valle
Guest
Ksenija Pavletic
Guest
Thierry Laugel
Guest
Regina Hodits
Guest
Sofia Ioannidou
Guest
Miguel Forte
Guest
John Ellis
Guest
Similar Podcasts
Discover related shows you might enjoy

BioCentury This Week
BioCentury

The Readout Loud
STAT

Biotech Hangout
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

The Long Run with Luke Timmerman
Timmerman Report

Odd Lots
Bloomberg

NEJM AI Grand Rounds
NEJM Group

Barron's Streetwise
Barron's

a16z Podcast
Andreessen Horowitz

HBR IdeaCast
Harvard Business Review

Invest Like the Best with Patrick O'Shaughnessy
Colossus | Investing & Business Podcasts

Nature Podcast
Springer Nature Limited

Science Magazine Podcast
Science Magazine

The Top Line
Fierce Life Sciences

Training Data
Sequoia Capital

Goldman Sachs Exchanges
Goldman Sachs
Deep-dive analytics for BioSpace
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is BioSpace?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.